Skip to content

Adaptation and Implementation of an Evidence-based Approach to Advance HIV Prevention and Care

Adaptation and Implementation of an Evidence-based Approach to Advance HIV Prevention and Care

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07495059
Enrollment
80
Registered
2026-03-27
Start date
2026-03-01
Completion date
2027-01-10
Last updated
2026-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Continuum of Care, HIV (Human Immunodeficiency Virus), Stigma

Keywords

HIV, Implementation Science, Continuum of Care

Brief summary

Transgender women in the intervention condition will attend TransAction individual risk reduction sessions; skill building and open group support sessions, and social events between baseline and 3-month assessment. Transgender women participants in the control condition will be invited to social events only.

Detailed description

80 transgender women will be randomized to either an intervention condition (receiving all TransAction activities) or a control condition (being invited to TransAction social events only). We will evaluate outcomes such as advancement along the HIV prevention/care continua, sexual risks, substance use, self-efficacy in services seeking, social support, stigma, general well-being, and quality of life at baseline, 3-month, and 6-month follow-ups. Furthermore, we will assess implementation outcomes such as fidelity, adaptation, feasibility, acceptability, and sustainability through implementation documentation, investigator evaluation, and survey/focus groups with peer facilitators and TW participants.

Interventions

BEHAVIORALTransAction

Immediately following the baseline, participants in the intervention condition will be invited to participate in the individual and group sessions, with topics around reducing HIV risk behaviors, regular HIV/CD4/viral load testing, ART/PrEP uptake and adherence, and family/social support, all to be completed within three months. All participants, including those in both intervention and control conditions, will be invited to two social events to disseminate health information, HIV prevention messages, and foster social support in a festive, party-style atmosphere.

Sponsors

University of California, Los Angeles
Lead SponsorOTHER
University of Medicine and Pharmacy at Ho Chi Minh City
CollaboratorOTHER
Friends Research Institute, Inc.
CollaboratorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 16 years of age or older * being male at birth and currently self-identified as a TW * currently living in Ho Chi Minh City adjacent areas and having no plans to move out of the areas in the next 6 months - have the cognitive capacity to participate in study activities as judged by the study recruiter.

Exclusion criteria

* have been involved in intervention adaptation activities previously with the study team * inability to give informed consent/assent

Design outcomes

Primary

MeasureTime frameDescription
Placement on HIV prevention/care continuaBaseline, 3-, and 6-monthsAn ordinal outcome from 1) HIV+; not taking ART; 2) HIV+; taking ART but not virally suppressed (including no viral load test in the last 6 months); 3) HIV+; taking ART and virtually suppressed; 4) HIV-, not having regular HIV testing; 5) HIV-, having regular HIV testing but not taking PrEP; and 6) HIV-; currently on PrEP. A higher value indicates better placement in HIV prevention/care continua.

Secondary

MeasureTime frameDescription
Self-efficacyBaseline, 3-, and 6-monthsSelf-efficacy in seeking healthcare and social services, as well as self-efficacy in negotiating condom use.
Social supportBaseline, 3-, and 6-monthsPerceived support from family members, peers, service providers, and online resources
General wellbeing and quality of lifeBaseline, 3-, and 6-monthsGeneral wellbing and quality of life will be measured using Short Form-12 and Hospital Anxiety and Depression Scale

Countries

Vietnam

Contacts

CONTACTChunqing Lin, PhD
lincq@ucla.edu3107940361

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 22, 2026